openPR Logo
Press release

Albumin Market Size, Challenges, Growth, Future Potential Of Industry 2023

07-29-2020 06:07 PM CET | Health & Medicine

Press release from: Allied Market Research

Albumin Market

Albumin Market

Albumin is a globular protein found in the liquid components of blood called plasma. It is the most abundant protein in the plasma, making up about 50% of the total protein in the blood. It plays an important role in maintaining proper oncotic pressure in the blood and transporting hormones, fatty acids and other compounds throughout the body. It is derived from plasma at fractionation and is widely used clinically to treat various diseases. Other types of albumin are used clinically. This includes human serum albumin, bovine serum albumin and recombinant albumin.

According to a new report titled Allied Market Research (Albumin Market, Products and Applications: Global Opportunity Analysis and Industry Forecast 2017-2023), the global albumin market value in 2016 is expected to reach $5,381 million. It reached $10,305 million in 2023, an annual average increase of 9.6% from 2017 to 2023.

Click here to access the free sample report: https://www.alliedmarketresearch.com/request-sample/2583

Factors driving the growth of the albumin market include increased prevalence of life-threatening diseases and conditions: surgical procedures, liver disease, trauma and burn cases. In addition, awareness of recombinant albumin products is increasing, demand for albumin products is skyrocketing, and the growth of non-therapeutic applications of albumin also promotes market growth. However, strict government regulations and reforms, and the risk of side effects after using albumin products, hinder market growth. Conversely, the development of cost-effective treatments, along with the mass production of albumin and the presence of an unexplored market in emerging countries, is expected to provide a favorable growth opportunity for the market.

The human serum albumin sector occupied the largest share in 2016, due to its high utilization rate with blood technology, its applicability to the treatment of various diseases and the improvement of human serum albumin production due to the emergence of advanced technology. However, the recombinant albumin segment is expected to grow at a high CAGR from 2017 to 2023.

The use of albumin for treatment is high because of the increased prevalence of trauma and burns and the number of surgical procedures. However, drug formulation and vaccine segments are expected to grow at high CAGRs during the forecast period.

Purchase Inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/2583

The main results of the albumin market:
• Bovine serum albumin segments accounted for about a quarter of the global albumin market in 2016.
• Recombinant albumin segment is expected to grow at the highest CAGR from 2017 to 2023.
• Media sector components accounted for about a fifth of the world market in 2016.
• Europe accounted for about one third of the world market in 2016.
• LAMEA is expected to provide profitable market growth opportunities from 2017 to 2023.

North America was the main source of revenue for the global albumin market in 2016 and is expected to dominate the market during the forecast period. This is due to the early approval of albumin products in this region and the high adoption of recombinant albumin.

However, the Asia-Pacific region is expected to grow at the highest CAGR during the study period due to improved economics, a surge in medical expenditures, and increased awareness of albumin products.

Get detailed (COVID-19 impact) analysis:https://www.alliedmarketresearch.com/human-albumin-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Albumin Market Size, Challenges, Growth, Future Potential Of Industry 2023 here

News-ID: 2099184 • Views: 242

More Releases from Allied Market Research

Ultrasonic Air Bubble Detectors Market Size & Share | Analysis - 2026
UPCOMING REPORT’S INTRODUCTION: According to an upcoming report of Allied Market Research, titled, “Ultrasonic Air Bubble Detectors Market”, the Ultrasonic Air Bubble Detectors market is expected to grow sustainably from 2020 to 2027. The report offers a comprehensive analysis of various growth drivers of the Ultrasonic Air Bubble Detectors market. The analysis ranges from revenue and operations to future growth opportunities. This comprehensive analysis of great importance for stakeholders to
World GPS Tracking Device Market - Opportunities and Forecasts, 2020-2027
Analyzing the current situation of pandemic, Allied market research has published a report t, which says, the GPS Tracking Device market is expected to grow at a faster pace by 2027. The researchers have intelligently made analysis and forecasts of the future growth by taking the past performance and data into consideration. The analysis offered by the report will surely provide valuable insights to the stakeholders of the GPS Tracking
Automotive Smart Helmet Market Statistics 2020: Advanced Technologies, Trends, C …
Allied Market Research published a new report, titled, "Automotive Smart Helmet Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Get detailed COVID-19 impact
Hybrid Funds Market Size, Share and Growth | Analysis - 2027
INTRODUCTION TO REPORT The report published by Allied market research, titled, “Hybrid Funds Market”, offers a comprehensive analysis of key growth drivers, key segments, development strategies, market opportunities, and competitive landscape. This study offers detailed insights for market players, investors, stakeholders, and new entrants to understand the industry dynamics and determine strategic steps to gain the competitive advantage. COVID_19 Scenarios: The Hybrid Funds has been the worst hit by COVID-19 globally. Based

All 5 Releases


More Releases for Albumin

Global Serum Albumin Market Research Report
This report studies the global Serum Albumin market status and forecast, categorizes the global Serum Albumin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Octapharma Kedrion CSL Behring Shire (Baxter) Grifols Hualan Bio Taibang Bio RAAS Greencross Geographically, this report studies
Global Glycated Albumin Market Growth 2019-2024
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy. Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Global Albumin Market $307 Million by 2021
According to a market research report Albumin Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc., the global albumin market is estimated to reach $307 Million in 2021, expanding at a CAGR of 2.4% from 2017 to 2021. The global albumin market segmentation is based on type (human serum albumin, bovine serum albumin, recombinant albumin), and its applications (drug formulation and drug delivery, vaccines, components of media). The global albumin market
Global Glycated Albumin Sales Market Report 2017
24 Market Reports provides a complete data analysis of Global Glycated Albumin Sales Market Report 2017 with Market value, Sales, Price, Industry Analysis and Forecast with the help of Industry Experts. In this report, the global Glycated Albumin market is expected to reach high by the end of 2022. Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated
Latest market Research | Glycated Albumin Sales 2017
This report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Glycated Albumin for these regions, from 2012 to 2022 (forecast), covering • United States • China • Europe • Japan • Southeast Asia • India Global Glycated Albumin market competition by top manufacturers/players, with Glycated Albumin sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including • Asahi Kasei Pharma • DIAZYME • Abnova • LifeSpan • Exocell • BSBE • Medicalsystem • Maccura • Leadman • Simes Sikma • NINGBO PUREBIO On the basis of product, this